Rajko Reljic Selected Research

Antigens

1/2024	Marked enhancement of the immunogenicity of plant-expressed IgG-Fc fusion proteins by inclusion of cholera toxin non-toxic B subunit within the single polypeptide.
1/2021	Systemic and Oral Immunogenicity of Porcine Epidemic Diarrhea Virus Antigen Fused to Poly-Fc of Immunoglobulin G and Expressed in ΔXT/FT Nicotiana benthamiana Plants.
1/2020	Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ.
1/2019	Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG.
1/2019	Inactivated Lactobacillus plantarum Carrying a Surface-Displayed Ag85B-ESAT-6 Fusion Antigen as a Booster Vaccine Against Mycobacterium tuberculosis Infection.
10/2016	Oral immunisation of mice with transgenic rice calli expressing cholera toxin B subunit fused to consensus dengue cEDIII antigen induces antibodies to all four dengue serotypes.
4/2015	Novel vaccination approach for dengue infection based on recombinant immune complex universal platform.
9/2014	Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model.
2/2014	Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
1/2013	Immune-complex mimics as a molecular platform for adjuvant-free vaccine delivery.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rajko Reljic Research Topics

Disease

32	Tuberculosis (Tuberculoses) 10/2023 - 03/2004
23	Infections 02/2024 - 03/2004
6	Communicable Diseases (Infectious Diseases) 01/2019 - 03/2011
5	Dengue (Dengue Fever) 01/2024 - 04/2015
3	Latent Tuberculosis 01/2020 - 05/2007
2	Inflammation (Inflammations) 01/2020 - 01/2019
2	Granuloma 03/2009 - 01/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Pulmonary Tuberculosis 01/2019
1	Leprosy (Hansen's Disease) 01/2018
1	Leishmaniasis 01/2018
1	Melioidosis 01/2018
1	Virus Diseases (Viral Diseases) 04/2015

Drug/Important Bio-Agent (IBA)

21	VaccinesIBA 02/2024 - 03/2011
13	AntigensIBA 01/2024 - 03/2004
8	AntibodiesIBA 01/2024 - 03/2004
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2014
7	Immunoglobulin A (IgA)IBA 01/2020 - 03/2004
6	CytokinesIBA 07/2010 - 05/2006
3	Peptides (Polypeptides)IBA 01/2024 - 01/2019
3	alpha-Crystallins (alpha-Crystallin)IBA 01/2020 - 03/2004
3	Monoclonal AntibodiesIBA 03/2011 - 03/2004
2	Immunoglobulin G (IgG)IBA 01/2024 - 01/2018
2	Cholera ToxinIBA 01/2024 - 10/2016
2	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 05/2006
2	NanovaccinesIBA 01/2020 - 01/2019
2	ChemokinesIBA 03/2009 - 01/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2009 - 03/2007
2	Interleukin-4 (Interleukin 4)IBA 01/2009 - 03/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	IronIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	IgA receptor (protein B)IBA 01/2020
1	LipidsIBA 01/2020
1	Apoprotein(a) (Apolipoprotein (a))IBA 01/2020
1	InterferonsIBA 01/2020
1	Transferrin (beta 2 Transferrin)IBA 01/2020
1	BCG Vaccine FDA Link 12/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	CarbohydratesIBA 01/2019
1	Liposomes (Liposome)IBA 01/2019
1	Subunit VaccinesIBA 01/2019
1	PhosphatidylserinesIBA 01/2019
1	Ag85B-ESAT-6 fusion antigenIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 12/2017
1	Combined VaccinesIBA 10/2016
1	Antigen-Antibody Complex (Immune Complex)IBA 04/2015
1	EpitopesIBA 04/2015
1	DEC-205 receptorIBA 03/2011
1	Protein Subunit VaccinesIBA 03/2011
1	LuciferasesIBA 03/2011
1	Therapeutic UsesIBA 03/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009
1	serum P-component (CIt)IBA 01/2009
1	lipoarabinomannan (LAM)IBA 12/2006
1	DNA VaccinesIBA 05/2006
1	AerosolsIBA 03/2004

Therapy/Procedure

4	Therapeutics 01/2020 - 05/2007
4	Immunotherapy 01/2019 - 05/2006
2	Drug Therapy (Chemotherapy) 01/2009 - 05/2007
1	Art Therapy 01/2023